Greenwood Capital Associates LLC Vertex Pharmaceuticals Inc Transaction History

Greenwood Capital Associates LLC

$755 Million
Q3 2024

A detailed history of Greenwood Capital Associates LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 20,524 shares of VRTX stock, worth $9.26 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares

20,524

Previous 21,193 3.16%

Holding current value

$9.26 Million

Previous $9.93 Million 3.91%

% of portfolio

1.27%

Previous 1.33%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$460.0 - $505.78 $307,740 - $338,366	-669 Reduced 3.16%	20,524 $9.55 Million
Q2 2024 Aug 08, 2024	BUY	$392.81 - $485.53 $415,592 - $513,690	1,058 Added 5.25%	21,193 $9.93 Million
Q1 2024 May 01, 2024	SELL	$407.69 - $446.08 $2.12 Million - $2.32 Million	-5,210 Reduced 20.56%	20,135 $8.42 Million
Q4 2023 Mar 05, 2024	BUY	$343.0 - $410.68 $883,568 - $1.06 Million	2,576 Added 11.31%	25,345 $10.3 Million
Q3 2023 Oct 18, 2023	SELL	$338.18 - $362.46 $1.84 Million - $1.97 Million	-5,429 Reduced 19.25%	22,769 $7.92 Million
Q2 2023 Aug 07, 2023	SELL	$314.42 - $351.91 $99,042 - $110,851	-315 Reduced 1.1%	28,198 $9.92 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $104,795 - $119,547	370 Added 1.31%	28,513 $8.98 Million
Q4 2022 Jan 26, 2023	SELL	$285.76 - $321.48 $650,389 - $731,688	-2,276 Reduced 7.48%	28,143 $0
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $211,944 - $236,480	-774 Reduced 2.48%	30,419 $8.81 Million
Q2 2022 Aug 10, 2022	BUY	$234.96 - $292.55 $7.27 Million - $9.05 Million	30,938 Added 12132.55%	31,193 $8.79 Million
Q1 2022 May 10, 2022	SELL	$221.42 - $260.97 $12.2 Million - $14.4 Million	-55,061 Reduced 99.54%	255 $67,000
Q4 2021 Feb 03, 2022	SELL	$177.01 - $223.45 $41,066 - $51,840	-232 Reduced 0.42%	55,316 $12.1 Million
Q3 2021 Oct 27, 2021	BUY	$181.39 - $202.99 $1.13 Million - $1.26 Million	6,219 Added 12.61%	55,548 $10.1 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $5.1 Million - $6.01 Million	27,202 Added 122.94%	49,329 $9.95 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $475,731 - $554,530	2,298 Added 11.59%	22,127 $4.76 Million
Q4 2020 Feb 09, 2021	BUY	$207.01 - $276.09 $4.1 Million - $5.47 Million	19,829 New	19,829 $4.69 Million

Others Institutions Holding VRTX

# of Institutions

1,721

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Account

Greenwood Capital Associates LLC Vertex Pharmaceuticals Inc Transaction History